An anonymous reader writes "California-based Geron has announced that the first embryonic stem cell trial may be in the not-so-distant future. Tom Okarma, Geron's CEO, recently announced that the company will be seeking permission from the FDA to begin clinical trials. From the article: 'Geron's plan is to treat people that have acute spinal injuries with oligodendrocyte progenitor cells grown from human ESCs. Oligodendrocyte cells support neurons in the brain and spine by sheathing them in myelin, a fat that helps neurons to transmit signals.'"
Attend or create a Slashdot 20th anniversary party! DEAL: For $25 - Add A Second Phone Number To Your Smartphone for life! Use promo code SLASHDOT25. Check out the new SourceForge HTML5 Internet speed test. ×